Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

An alternative conditioning regimen for induction of specific skin graft tolerance across full major histocompatibility complex barriers.

de Vries-van der Zwan A, van der Pol MA, de Waal LP, Boog CJ.

Transpl Immunol. 1998 Sep;6(3):147-51.

PMID:
9848220
2.

Long-term detection of microchimaerism in peripheral blood after pretransplantation blood transfusion.

Vervoordeldonk SF, Doumaid K, Remmerswaal EB, ten Berge IJ, Wilmink JM, de Waal LP, Boog CJ.

Br J Haematol. 1998 Sep;102(4):1004-9.

PMID:
9734651
3.

Specific tolerance induction and organ transplantation.

de Vries-van der Zwan A, Besseling AC, van der Pol MA, de Waal LP, Boog CJ.

Leuk Lymphoma. 1998 Sep;31(1-2):131-42. Review.

PMID:
9720723
4.

Molecular heterogeneity of second and fourth components of complement and their genes in systemic sclerosis and association of HLA alleles A1, B8 and DR3 with limited and DR5 with diffuse systemic sclerosis.

Venneker GT, van den Hoogen FH, van Meegen M, de Kok-Nazaruk M, Hulsmans RF, Boerbooms AM, de Waal LP, Bos JD, Asghar SS.

Exp Clin Immunogenet. 1998;15(2):90-9.

PMID:
9691203
5.

Haematopoietic stem cells can induce specific skin graft acceptance across full MHC barriers.

de Vries-van der Zwan A, van der Pol MA, Besseling AC, de Waal LP, Boog CJ.

Bone Marrow Transplant. 1998 Jul;22(1):91-8.

6.

Donor-specific immunological non-responsiveness after liver transplantation.

van den Berg AP, de Haan A, Hepkema BG, van Dijk E, van Twuyver E, Klompmaker IJ, de Leij LH, de Waal LP, Slooff MJ, The TH.

Transpl Int. 1998;11 Suppl 1:S239-41.

7.

HLA-DRB4 gene encoded HLA-DR53 specificity segregating with the HLA-DR7, -DQ9 haplotype: unusual association.

Lardy NM, van der Horst AR, van de Weerd MJ, de Waal LP, Bontrop RE.

Hum Immunol. 1998 Feb;59(2):115-8.

PMID:
9536434
8.

Full-length cDNA nucleotide sequence of a serologically undetectable HLA-DQA1 allele: HLA-DQA1*"LA".

Lardy NM, Otting N, van der Horst AR, Bontrop RE, de Waal LP.

Tissue Antigens. 1997 Oct;50(4):334-9.

PMID:
9349615
9.

Influence of HLA-DRB1* incompatibility on the occurrence of rejection episodes and graft survival in serologically HLA-DR-matched renal transplant combinations.

Lardy NM, van der Horst AR, ten Berge IJ, Surachno S, Wilmink JM, de Waal LP.

Transplantation. 1997 Aug 27;64(4):612-6.

PMID:
9293875
10.

Specific tolerance induction and transplantation: a single-day protocol.

de Vries-van der Zwan A, Besseling AC, de Waal LP, Boog CJ.

Blood. 1997 Apr 1;89(7):2596-601.

11.

Stem cell transfusion as a new method for the induction of tolerance in organ transplantation.

de Vries-van der Zwan A, van der Pol MA, Besseling AC, de Waal LP, Boog CJ.

Transplant Proc. 1997 Feb-Mar;29(1-2):1209-10. No abstract available.

PMID:
9123276
12.

No tolerance induction with cryopreserved bone marrow cells after allogeneic kidney transplantation and antilymphocyte globulin in rhesus monkeys.

Hollander AA, de Waal LP, van Bockel HJ, Jonker M, Claas FH, van der Voort Maarschalk MF, Bruijn JA, van der Woude FJ.

Transpl Int. 1997;10(3):249-50. No abstract available.

13.

5' regulatory nucleotide sequence of an HLA-A*0101null allele.

Lardy NM, Otting N, van der Horst AR, Bontrop RE, de Waal LP.

Immunogenetics. 1997;46(2):152-5.

PMID:
9162102
14.

A substantial level of mixed chimerism is required for the induction of permanent transplantation tolerance.

de Vries-van der Zwan A, Besseling AC, van Twuyver E, Boog CJ, de Waal LP.

Transpl Immunol. 1996 Sep;4(3):232-40.

PMID:
8893455
15.

Comparison of T cell responses in patients with a long-term surviving renal allograft versus a long-term surviving liver allograft. It's a different world.

van Twuyver E, de Hoop J, ten Berge RJ, Wilmink JM, Lems SP, van de Berg AP, Slooff MJ, de Waal LP.

Transplantation. 1996 May 15;61(9):1392-7.

PMID:
8629303
16.

HLA typing in congenital toxoplasmosis.

Meenken C, Rothova A, de Waal LP, van der Horst AR, Mesman BJ, Kijlstra A.

Br J Ophthalmol. 1995 May;79(5):494-7.

17.

Missing T-cell receptor V beta families following blood transfusion. The role of HLA in development of immunization and tolerance.

Munson JL, van Twuyver E, Mooijaart RJ, Roux E, ten Berge IJ, de Waal LP.

Hum Immunol. 1995 Jan;42(1):43-53.

PMID:
7751159
18.

Anti-CD3 treatment facilitates engraftment of full H-2-disparate donor bone marrow cells and subsequent skin allograft tolerance.

de Vries-van Der Zwan A, Besseling AC, Kievits F, van Twuyver E, de Waal LP.

Transplantation. 1994 Sep 15;58(5):610-7.

PMID:
7522366
19.

Associations between HLA frequencies and pathogenic features of human immunodeficiency virus type 1 infection in seroconverters from the Amsterdam cohort of homosexual men.

Klein MR, Keet IP, D'Amaro J, Bende RJ, Hekman A, Mesman B, Koot M, de Waal LP, Coutinho RA, Miedema F.

J Infect Dis. 1994 Jun;169(6):1244-9.

PMID:
8195600
20.

IgG antibodies against an HLA antigen are associated with activated cytotoxic T cells against this antigen, IgM are not.

Roelen DL, van Bree J, Witvliet MD, Habraken I, van Beelen E, van't Sant PH, de Waal LP, van Rood JJ, Claas FH.

Transplantation. 1994 May 15;57(9):1388-92.

PMID:
8184480
21.

High-affinity cytotoxic T lymphocytes after non-HLA-sharing blood transfusion--the other side of the coin.

van Twuyver E, Mooijaart RJ, ten Berge IJ, van der Horst AR, Wilmink JM, Claas FH, de Waal LP.

Transplantation. 1994 Apr 27;57(8):1246-51.

PMID:
8178352
22.

Efficiency of antibodies directed against adhesion molecules to prolong skin graft survival in mice.

van Kooyk Y, de Vries-van der Zwan A, de Waal LP, Figdor CG.

Transplant Proc. 1994 Apr;26(2):401-3. No abstract available.

PMID:
7909626
23.

Serologic HLA typing in cryptogenic Lennox-Gastaut syndrome.

van Engelen BG, de Waal LP, Weemaes CM, Renier WO.

Epilepsy Res. 1994 Jan;17(1):43-7.

PMID:
8174524
24.

Immunomodulating effect of blood transfusion: mechanisms and clinical implications.

De Waal LP.

Vox Sang. 1994;67 Suppl 3:183-4. Review. No abstract available.

PMID:
7975488
25.

HLA associations in vitiligo patients in the Dutch population.

Venneker GT, de Waal LP, Westerhof W, D'Amaro J, Schreuder GM, Asghar SS.

Dis Markers. 1993 Nov;11(4):187-90.

PMID:
8112023
26.

Fatigue, sleep disturbances and circadian rhythm in multiple sclerosis.

Taphoorn MJ, van Someren E, Snoek FJ, Strijers RL, Swaab DF, Visscher F, de Waal LP, Polman CH.

J Neurol. 1993 Jul;240(7):446-8.

PMID:
8410088
27.

Selective changes in human T-cell receptor repertoire after blood transfusion.

Munson JL, van Twuyver E, Mooijaart RJ, de Waal LP.

Transplant Proc. 1993 Feb;25(1 Pt 1):492-3. No abstract available.

PMID:
8438392
28.

Molecular heterogeneity of the fourth component of complement (C4) and its genes in vitiligo.

Venneker GT, Westerhof W, de Vries IJ, Drayer NM, Wolthers BG, de Waal LP, Bos JD, Asghar SS.

J Invest Dermatol. 1992 Dec;99(6):853-8.

29.

cis-acting regulatory elements abrogate allele-specific HLA class I gene expression in healthy individuals.

Lardy NM, Bakas RM, van der Horst AR, van Twuyver E, Bontrop RE, de Waal LP.

J Immunol. 1992 Apr 15;148(8):2572-7.

PMID:
1560211
30.

HLA-A29 subtypes and birdshot chorioretinopathy.

de Waal LP, Lardy NM, van der Horst AR, Baarsma GS, Kijlstra A, Noens L, Priem HA.

Immunogenetics. 1992;35(1):51-3. No abstract available.

PMID:
1729172
31.

Pretransplantation blood transfusion revisited.

van Twuyver E, Mooijaart RJ, ten Berge IJ, van der Horst AR, Wilmink JM, Kast WM, Melief CJ, de Waal LP.

N Engl J Med. 1991 Oct 24;325(17):1210-3.

32.

Fine specificity of the alloantiserum MSD-51: epitope mapping of HLA-DRw53 determinants.

Lardy NM, van der Horst AR, van den Berg-Loonen EM, Bontrop RE, de Waal LP.

Hum Immunol. 1991 Sep;32(1):65-71.

PMID:
1723063
33.

Frequency analysis of HLA-specific cytotoxic T lymphocyte precursors in humans.

Breur-Vriesendorp BS, Vingerhoed J, van Twuyver E, de Waal LP, Ivanyi P.

Transplantation. 1991 May;51(5):1096-103.

PMID:
2031263
34.

Restriction fragment length polymorphism of the tumor necrosis factor region in patients with ankylosing spondylitis.

Verjans GM, van der Linden SM, van Eys GJ, de Waal LP, Kijlstra A.

Arthritis Rheum. 1991 Apr;34(4):486-9.

PMID:
1672816
35.

Hereditary deficiency of C5 in association with discoid lupus erythematosus.

Asghar SS, Venneker GT, van Meegen M, Meinardi MM, Hulsmans RF, de Waal LP.

J Am Acad Dermatol. 1991 Feb;24(2 Pt 2):376-8.

PMID:
1999552
36.

Mechanisms of transplantation tolerance: do anti-idiotypic antibodies play a role?

de Waal LP, van Twuyver E, Mooijaart RJ, Lardy NM, Kast WM, Melief CJ.

Transplant Proc. 1991 Feb;23(1 Pt 1):155-6. No abstract available.

PMID:
1824971
37.

Blood transfusion and allograft survival: is mixed chimerism the solution for tolerance induction in clinical transplantation?

de Waal LP, van Twuyver E.

Crit Rev Immunol. 1991;10(5):417-25. Review. No abstract available.

PMID:
2021424
38.
40.

Effect of a Tyr-to-His point-mutation at position 59 in the alpha-1 helix of the HLA-B27 class-I molecule on allospecific and virus-specific cytotoxic T-lymphocyte recognition.

Breur-Vriesendorp BS, Vingerhoed J, Kuijpers KC, van der Horst AR, de Waal LP, Kievits F, Ivanyi P.

Scand J Rheumatol Suppl. 1990;87:36-43.

PMID:
1701919
41.

Allograft tolerance induction in adult mice associated with functional deletion of specific CTL precursors.

van Twuyver E, Kast WM, Mooijaart RJ, Wilmink JM, Melief CJ, de Waal LP.

Transplantation. 1989 Nov;48(5):844-7.

PMID:
2815256
42.

HLA-B27+ acute anterior uveitis and other antigens of the major histocompatibility complex.

Derhaag PJ, van der Horst AR, de Waal LP, Feltkamp TE.

Invest Ophthalmol Vis Sci. 1989 Oct;30(10):2160-4.

PMID:
2793356
43.

Blood lymphocytes from ankylosing spondylitis patients fail to induce disease-specific cytotoxic T lymphocytes.

Breur-Vriesendorp BS, Post FA, de Waal LP, Blokland E, Pool J, van der Linden S, Dekker-Saeys BJ, Goulmy E, Ivanyi P.

Hum Immunol. 1989 Jul;25(3):149-55.

PMID:
2670850
44.

Selection of cross-match negative HLA-A and/or -B mismatched donors for highly sensitized patients.

Claas FH, Gijbels Y, von Veen A, de Waal LP, D'Amaro J, Persijn GG, van Rood JJ.

Transplant Proc. 1989 Feb;21(1 Pt 1):665-6. No abstract available.

PMID:
2650216
45.

Transfusion-induced skin allograft enhancement across an H-2 class-I mismatch is caused by a clonal deletion of donor-specific cytotoxic T-lymphocyte precursors within the allograft.

van Twuyver E, Kast WM, Mooijaart RJ, Melief CJ, de Waal LP.

Transplant Proc. 1989 Feb;21(1 Pt 1):1169-70. No abstract available.

PMID:
2650087
46.

Analysis of the HLA-A10-crossreacting group of antigens by one-dimensional isoelectric focusing.

van der Horst AR, Lardy NM, de Waal LP.

Immunogenetics. 1989;29(1):1-5.

PMID:
2908874
47.

Transplantation of highly sensitized patients on the basis of acceptable HLA-A and B mismatches.

Claas FH, de Waal LP, Beelen J, Reekers P, Berg-Loonen PV, de Gast E, D'Amaro J, Persijn GG, Zantvoort F, van Rood JJ.

Clin Transpl. 1989:185-90.

PMID:
2487564
48.

Mechanism of skin allograft enhancement across an H-2 class I mutant difference. Evidence for involvement of veto cells.

Kast WM, Van Twuyver E, Mooijaart RJ, Verveld M, Kamphuis AG, Melief CJ, De Waal LP.

Eur J Immunol. 1988 Dec;18(12):2105-8.

PMID:
2975604
49.

A special strategy to increase the chance of finding cross-match negative kidneys for highly sensitized patients.

Claas FH, Gijbels Y, van der Velden-de Munck JJ, de Waal LP, D'Amaro J, Hendriks GF, Persijn GG, van Rood JJ.

Transplant Proc. 1988 Oct;20(5):947-8. No abstract available.

PMID:
3055538
50.

Different linkage disequilibria of HLA-B27 subtypes and HLA-C locus alleles.

Breur-Vriesendorp BS, de Waal LP, Ivanyi P.

Tissue Antigens. 1988 Aug;32(2):74-7.

PMID:
3264088

Supplemental Content

Loading ...
Support Center